Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 2Depression 2Anxiety Disorders 2Neoplasm Metastasis 1Hospice 1

Interventions

Therapeutics 6Escitalopram 4Yoga 3Surveys and Questionnaires 3Sugars 2Psychiatric Rehabilitation 2Psilocybin 2Ketamine 2Vorinostat 1Ultraviolet Therapy 1Typhoid-Paratyphoid Vaccines 1Therapeutic Touch 1Temozolomide 1Self-Help Groups 1Selective Serotonin Reuptake Inhibitors 1Saline Solution 1Psychosocial Intervention 1Niacin 1Minocycline 1Methylphenidate 1Melatonin 1Massage 1Mass Screening 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Interleukin-2 1Infliximab 1Imagery, Psychotherapy 1Fatty Acids, Omega-3 1Exercise Test 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Depression × Psilocybin × Clear all
NCT00957359 2020-10-20

Psilocybin Cancer Anxiety Study

NYU Langone Health

Phase EARLY_PHASE1 Completed
29 enrolled 59 charts

Anxiety Disorders, Depression, Neoplasms

NCT00465595 2018-07-19

Psychopharmacology of Psilocybin in Cancer Patients

Johns Hopkins University

Phase 2 Completed
56 enrolled 8 charts

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡